Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Canopy Growth Corp (CGC)

Canopy Growth Corp (CGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 453,202
  • Shares Outstanding, K 368,457
  • Annual Sales, $ 193,330 K
  • Annual Income, $ -429,870 K
  • EBIT $ -58 M
  • EBITDA $ -27 M
  • 60-Month Beta 0.43
  • Price/Sales 2.01
  • Price/Cash Flow N/A
  • Price/Book 0.87

Options Overview Details

View History
  • Implied Volatility 128.59% (-8.93%)
  • Historical Volatility 156.50%
  • IV Percentile 34%
  • IV Rank 19.71%
  • IV High 277.46% on 04/08/25
  • IV Low 92.05% on 01/29/25
  • Expected Move (DTE 4) 0.2295 (18.66%)
  • Put/Call Vol Ratio 0.24
  • Today's Volume 17,913
  • Volume Avg (30-Day) 68,694
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 616,202
  • Open Int (30-Day) 601,251
  • Expected Range 1.0005 to 1.4595

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.03
  • Number of Estimates 3
  • High Estimate 0.01
  • Low Estimate -0.07
  • Prior Year -0.76
  • Growth Rate Est. (year over year) +96.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1100 +10.81%
on 12/10/25
2.3800 -48.32%
on 12/18/25
+0.1000 (+8.85%)
since 12/09/25
3-Month
0.9960 +23.49%
on 11/21/25
2.3800 -48.32%
on 12/18/25
-0.4200 (-25.45%)
since 10/09/25
52-Week
0.7700 +59.74%
on 04/09/25
2.9000 -57.59%
on 02/06/25
-1.4300 (-53.76%)
since 01/08/25

Most Recent Stories

More News
Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy

This news release constitutes a “designated news release” for the purposes of Canopy Growth’s prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024...

WEED.TO : 1.73 (-2.81%)
CGC : 1.2300 (-4.65%)
The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations

Federal rescheduling efforts, coupled with improved corporate balance sheets, may finally unlock long-awaited profitability for cannabis-sector leaders.

TLRY : 9.18 (+0.55%)
CGC : 1.2300 (-4.65%)
Canopy Growth Is Surging and Analysts Still Think It Can Gain 40% from Here

Canopy Growth soars on reports the White House is considering reclassifying cannabis as a “Schedule III” drug. Here’s why CGC shares currently look attractive as a long-term holding.

CGC : 1.2300 (-4.65%)
Want to Jump on the Cannabis Stocks Rally? This Company Has Been the Top-Performing Player in 2025.

Down almost 70% from all-time highs, Curaleaf stock offers significant upside potential given its widening free cash flow margins.

CURLF : 2.5300 (-1.55%)
TLRY : 9.18 (+0.55%)
CGC : 1.2300 (-4.65%)
Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada’s Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand

This news release constitutes a “designated news release” for the purposes of Canopy Growth’s prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024...

WEED.TO : 1.73 (-2.81%)
MTLNF : 0.4250 (-6.37%)
CGC : 1.2300 (-4.65%)
MTLC.CN : 0.6700 (-2.90%)
Canopy Growth Launches Claybourne Gassers Liquid Diamonds All-In-One Vapes in Canada, Expanding Footprint in High-Growth Vape Segment

New high-performance AIO vapes and infused pre-roll variety packs further Claybourne’s continued growth as one of the fastest-rising brands 1 in Canada’s adult-use market

WEED.TO : 1.73 (-2.81%)
CGC : 1.2300 (-4.65%)
Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels

Expanded formats strengthen Canopy Growth’s medical offering as patient demand rises

WEED.TO : 1.73 (-2.81%)
CGC : 1.2300 (-4.65%)
Canopy Growth Just Topped Earnings Estimates. Should You Buy, Sell, or Hold CGC Stock for November 2025?

Canopy Growth’s latest results showcased stronger execution and renewed momentum across key markets. Is CGC stock finally turning the corner this November?

$SPX : 6,966.28 (+0.65%)
CGC : 1.2300 (-4.65%)
Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Balance Sheet

Canada adult-use revenue up 30% in Q2 FY2026 and 37% year-to-date, reflecting the benefits of our focused commercial strategy and more disciplined execution Canada medical...

WEED.TO : 1.73 (-2.81%)
CGC : 1.2300 (-4.65%)
Canopy Growth to Report Second Quarter Fiscal 2026 Financial Results on November 7, 2025

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2026 ended September 30, 2025 before financial...

WEED.TO : 1.73 (-2.81%)
CGC : 1.2300 (-4.65%)

Business Summary

Canopy Growth Corporation is a cannabis company. It offers dry cannabis and oil products primarily under the Tweed brand. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

See More

Key Turning Points

3rd Resistance Point 1.3967
2nd Resistance Point 1.3633
1st Resistance Point 1.2967
Last Price 1.2300
1st Support Level 1.1967
2nd Support Level 1.1633
3rd Support Level 1.0967

See More

52-Week High 2.9000
Fibonacci 61.8% 2.0863
Fibonacci 50% 1.8350
Fibonacci 38.2% 1.5837
Last Price 1.2300
52-Week Low 0.7700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar